Vitamin D3 Supplementation Modulates Inflammatory Protein CHI3L1/YKL-40 and Oxidative Stress Status in Multiple Sclerosis.
- 2025-11-23
- Clinical Trial · n = 35
- Neuropsychopharmacology reports 45(4)
- Sevda Asadpour
- Mehrdokht Mazdeh
- Jamshid Karimi
- Iraj Khodadadi
- Gholamreza Shafiee
- PubMed: 41277171
- DOI: 10.1002/npr2.70076
- High evidence
- Clinical
Antioxidant capacity improved, as demonstrated by elevated TAC (0.622 ± 0.138 to 0.797 ± 0.15 mmol Fe2+/L; p < 0.001)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- 50 000 IU/week